Latest Breaking News On - Catherine tangen - Page 1 : comparemela.com

Extended lymph node removal does not benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times. It does, however, increase the risk of adverse events (side effects) and post-surgical death. These primary results from the phase 3 SWOG S1011 clinical trial are being delivered in an oral presentation at the 2023 annual meeting of the American Society of Clinical Oncology in Chicago on June 5 (Abstract 4508).

United statesFranciscog larosaIanm thompson jrAjai alvaSumantak palRoberts svatekAdams kibelWassim kassoufKamal poharAashish kamatSethp lernerTheresam koppieArthuri sagalowskySiamak daneshmandCatherine tangenAnne schuckman

Strong Link Between Bone Biomarkers and Prostate Cancer Survival

New study led by UC Davis Comprehensive Cancer Center could improve outcomes for common cancer found in 1 in 8 men.

Santa monicaUnited statesSan antonioNorthwestern universitySalt lake cityCatherine tangenJingsong zhangIan thompsonNeeraj agarwalLara jrErik gertzLos angelesEdward mayersonMichael leblancMamta parikhMaha hussain

Bone Biomarkers Tied to Prostate Cancer Survival

Bone Biomarkers Tied to Prostate Cancer Survival
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesSanta monicaSalt lake cityNorthwestern universityShilpa guptaMaha hussainAmir goldkornIan thompsonLos angelesPrzemyslaw twardowskiNicholasj vogelzangCatherine tangenLara jrJingsong zhangErik gertz

Prostate cancer partnership honored for statistical excellence in accelerating therapeutic advances

Prostate cancer partnership honored for statistical excellence in accelerating therapeutic advances
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesBoris freidlinMarc buyseMax parmarWanling xieMeredith reganCatherine tangenMatt sydesJayne tierneyLaurence colletteSusan halabiJames dignamNational cancer instituteDana farber department of data scienceDana farber cancer institute christopher sweeneyAmerican statistical association

Cabozantinib most effective treatment for metastatic papillary kidney cancer

E-Mail IMAGE: Sumanta Pal, MD, a SWOG Cancer Research Network researcher and City of Hope physician, led a study that sets a new standard of care for metastatic papillary kidney cancer view more Credit: City of Hope In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practice. These findings will be presented at ASCO s virtual 2021 Genitourinary Cancers Symposium on Feb. 13, 2021 at 1 p.m. ET. The findings will be simultaneously published in

United statesWayne state universityJohn wrightScott coleLos angelesCatherine tangenIanm thompson jrNaomi balzer haasDanielj georgeGeorga bjarnasonMark steinUlka vaishampayanMaria tretiakovaDaniel yc hengBrian shuchAdebowale adeniran